http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107744518-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336 |
| filingDate | 2017-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107744518-B |
| titleOfInvention | Application of pemetrexed in treating colorectal cancer |
| abstract | The invention discloses an application of an etomoxider in treating colorectal cancer. In particular to the application of the pemetrexed in preparing medicaments for preventing and treating intestinal cancer, in particular to medicaments for inhibiting intestinal cancer metastasis. The research of the invention shows that the nemock can obviously inhibit the clone formation of the colorectal cancer cells under the condition of losing nests, promote the anoikis of the colorectal cancer cells, inhibit the transfer capability of the colorectal cancer cells in vivo, and have obvious treatment effect on the colorectal cancer, especially obvious effect of inhibiting the colorectal cancer transfer, so the nemock can be used for treating the colorectal cancer transfer. The invention not only provides a new application of the Emock house, expands the clinical application field of the Emock house, but also provides a new treatment approach for treating colorectal cancer metastasis, and has good popularization and application prospects. |
| priorityDate | 2017-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.